VitamFero Overview
- Year Founded
-
2005
- Status
-
Out of Business
- Employees
-
14
- Latest Deal Type
-
Liquidation
- Investors
-
1
VitamFero General Information
Description
Developer of anti-infective vaccines intended to offer treatment to the people in France. The company's vaccines are based on a patented technology that designs, develops, registers and commercializes it, enabling physicians to offer remedy against pests of the family Apicomplexa.
Contact Information
Website
www.vitamfero.comCorporate Office
- 8 rue André Le Nôtre
- 49100 Angers
- France
Corporate Office
- 8 rue André Le Nôtre
- 49100 Angers
- France
VitamFero Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Bankruptcy: Liquidation | 04-Jul-2018 | Completed | Bankruptcy: Liquidation | |||
| 4. Grant | 20-Jan-2016 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series C) | 28-May-2015 | Completed | Generating Revenue | |||
| 2. Later Stage VC | 22-Feb-2011 | $2.04M | $2.58M | Completed | Generating Revenue | |
| 1. Seed Round | 29-Sep-2009 | $535K | $535K | Completed | Startup |
VitamFero Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| ABSA P4 | ||||||||
| ABSA P4 | ||||||||
| ABSAP1 | ||||||||
| Ordinary | 1,244 | $11.170950 | $28.35 | $28.35 | 1x | $28.35 | 0.99% | |
| BSA1 | 6,618 | $11.170950 | $28.35 | $28.35 | 1x | $28.35 | 5.25% |
VitamFero Comparisons
Industry
Financing
Details
VitamFero Competitors (5)
One of VitamFero’s 5 competitors is Genentech, a Formerly VC-backed company based in South San Francisco, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Genentech | Formerly VC-backed | South San Francisco, CA | ||||
| Volastra | Venture Capital-Backed | New York, NY | ||||
| Ability Pharma | Private Equity-Backed | Cerdanyola, Spain | ||||
| Gesynta Pharma | Venture Capital-Backed | Stockholm, Sweden | ||||
| Ona Therapeutics | Venture Capital-Backed | Barcelona, Spain |
VitamFero Patents
VitamFero Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2019008272-A1 | New attenuated strains of apicomplexa and their use as antigen vectors for the prevention of infectious diseases | Inactive | 03-Jul-2017 | ||
| FR-3068364-A1 | Use of sarcocystidae strains as multi-combining antigen vectors for the prevention of infectious diseases | Inactive | 03-Jul-2017 | ||
| WO-2019008274-A1 | Use of sarcocystidae strains as multi-recombinant antigen vectors for the prevention of infectious diseases | Inactive | 03-Jul-2017 | ||
| WO-2019008273-A1 | Use of strains of sarcocystidae to prevent infectious diseases in poultry | Inactive | 03-Jul-2017 | ||
| AU-2015259221-A1 | Methods for freeze-drying and rehydrating biologics | Active | 14-May-2014 | A61K39/002 |
VitamFero Signals
VitamFero Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| ACI Industrie | Corporation | Minority |
VitamFero FAQs
-
When was VitamFero founded?
VitamFero was founded in 2005.
-
Where is VitamFero headquartered?
VitamFero is headquartered in Angers, France.
-
What is the size of VitamFero?
VitamFero has 14 total employees.
-
What industry is VitamFero in?
VitamFero’s primary industry is Discovery Tools (Healthcare).
-
Is VitamFero a private or public company?
VitamFero is a Private company.
-
What is VitamFero’s current revenue?
The current revenue for VitamFero is .
-
How much funding has VitamFero raised over time?
VitamFero has raised $7.36M.
-
Who are VitamFero’s investors?
ACI Industrie has invested in VitamFero.
-
Who are VitamFero’s competitors?
Genentech, Volastra, Ability Pharma, Gesynta Pharma, and Ona Therapeutics are competitors of VitamFero.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process